Lyme Disease

Viral Genetics Issues Company Update for First Half of 2010

Published in Gastroenterology Week, June 14th, 2010

New grants to its lead scientist have enabled biotech firm Viral Genetics, Inc., (Pink Sheets: VRAL), to accelerate the pace of its research, hire additional staff and move closer to its goal of bringing drug compounds to the marketplace. The company is testing drug therapies for autoimmune diseases, drug resistant cancers, strep, and staph, as well as investigating bio-fuels.

As a result of her move to Texas, scientist Dr. M. Karen Newell, Ph.D., has obtained nearly $1 million in new funding to support her promising research. She has transitioned to a new position at Texas A&M University Health Sciences Center that enables her to spend much more of her time in the...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gastroenterology Week

Source: Gastroenterology Week (2010-06-14)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry